Thimble Point Acquisition Corp. Warrant

1D
1W
1M
3M
YTD
1Y
5Y
ALL

Why Robinhood?

You can watch THMAW and buy or sell other stocks, options, and ETFs commission-free!

About THMAW

Pear Therapeutics, Inc. is a commercial-stage healthcare company pioneering a new class of software-based medicines, sometimes referred to as Prescription Digital Therapeutics (PDT), which use software to treat diseases directly. The firm aims to redefine medicine by discovering, developing, and delivering clinically validated software-based therapeutics to provide better outcomes for patients, smarter engagement and tracking tools for clinicians, and cost-effective solutions for payers. It has a pipeline of products and product candidates across therapeutic areas, including the first three PDTs with disease treatment claims from the FDA. 

CEO
Christopher D. T. Guiffre, MBA
CEOChristopher D. T. Guiffre, MBA
Employees
Employees
Headquarters
Boston, Massachusetts
HeadquartersBoston, Massachusetts
Founded
2020
Founded2020
Employees
Employees

THMAW Key Statistics

Market cap
Market cap
Price-Earnings ratio
Price-Earnings ratio
Dividend yield
Dividend yield
Average volume
Average volume
High today
High today
Low today
Low today
Open price
Open price
Volume
0.00
Volume0.00
52 Week high
$0.0498
52 Week high$0.0498
52 Week low
52 Week low
All investments involve risks, including the loss of principal. Securities trading offered through Robinhood Financial LLC, Member SIPC and a registered broker-dealer.